SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-096378
Filing Date
2024-09-03
Accepted
2024-09-03 16:18:05
Documents
1
Group Members
PETER KOLCHINSKYRA CAPITAL HEALTHCARE FUND, L.P.RAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2423238d1_sc13da.htm SC 13D/A 63210
  Complete submission text file 0001104659-24-096378.txt   64986
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Subject) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-94570 | Film No.: 241274310
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)